Australia markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.01+0.33 (+2.83%)
At close: 4:00PM EST

12.42 +0.41 (3.41%)
Pre-market: 6:20AM EST

Currency in USD
Earnings estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
No. of analysts9499
Avg. Estimate-0.22-0.18-1.17-0.61
Low estimate-0.29-0.2-1.26-1.81
High estimate-0.17-0.14-1.130.44
Year ago EPS-0.38-0.26-1.21-1.17
Revenue estimateCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
No. of analysts9489
Avg. Estimate1.11M660k3.07M76.94M
Low estimate70k200k2.06M1.1M
High estimate2.8M1.58M4.63M302.2M
Year ago sales279k1.33M4.11M3.07M
Sales growth (year/est)297.80%-50.30%-25.30%2,406.20%
Earnings history30/12/201930/03/202029/06/202029/09/2020
Est. EPS-0.24-0.22-0.17-0.19
Actual EPS-0.38-0.26-0.830.11
Difference-0.14-0.04-0.660.3
Surprise %-58.30%-18.20%-388.20%157.90%
EPS trendCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
Current estimate-0.22-0.18-1.17-0.61
7 days ago-0.22-0.18-1.17-0.62
30 days ago-0.22-0.18-1.17-0.59
60 days ago-0.22-0.18-1.17-0.46
90 days ago-0.22-0.18-1.17-0.46
EPS revisionsCurrent qtr. (Dec 2020)Next qtr. (Mar 2021)Current year (2020)Next year (2021)
Up last 7 daysN/A1N/A1
Up last 30 daysN/A1N/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesINOIndustrySector(s)S&P 500
Current qtr.42.10%N/AN/AN/A
Next qtr.30.80%N/AN/AN/A
Current year3.30%N/AN/AN/A
Next year47.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A